3.71
3.71 (-0.58%)
As of Mar 06, 2024
Armata Pharmaceuticals, Inc. [ARMP]
Source:
Company Overview
We are a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using our proprietary bacteriophage-based technology. Bacteriophages or phages have a powerful and highly differentiated mechanism of action that enables binding to and killing specific bacteria, in contrast to traditional broad-spectrum antibiotics.
Country | United States |
Headquarters | marina del rey, california |
Phone Number | 310-665-2928 |
Industry | manufacturing |
CEO | Brian Varnum |
Website | https://www.armatapharma.com |